Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Cognitive Dysfunction × Radiosurgery × Clear all

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Brain Neoplasms 113 Carcinoma, Non-Small-Cell Lung 108 Prostatic Neoplasms 96 Neoplasm Metastasis 79 Lung Neoplasms 63 Pancreatic Neoplasms 60 Carcinoma, Hepatocellular 54 Breast Neoplasms 43 Melanoma 41 Carcinoma, Renal Cell 29 Neoplasms 28 Glioblastoma 22 Colorectal Neoplasms 20 Squamous Cell Carcinoma of Head and Neck 19 Liver Neoplasms 16 Small Cell Lung Carcinoma 13 Head and Neck Neoplasms 13 Sarcoma 12 Kidney Neoplasms 12 Glioma 11 Recurrence 9 Urinary Bladder Neoplasms 7 Gliosarcoma 7 Central Nervous System Neoplasms 7 Adenocarcinoma 7 Radiation Injuries 6 Ovarian Neoplasms 6 Neuroma, Acoustic 6 Meningioma 6 Adenocarcinoma of Lung 6

Interventions

Exercise 6 Transcranial Direct Current Stimulation 4 Neuropsychological Tests 4 Memantine 3 Walking 2 Standard of Care 2 Patient Reported Outcome Measures 2 Methods 2 Electroencephalography 2 Drug Therapy 2 Donepezil 2 Cognitive Behavioral Therapy 2 mazdutide 1 lithium sulfate 1 lime 1 enzalutamide 1 beta Carotene 1 acetaminophen, aspirin, caffeine drug combination 1 XENP 1595 1 Vitamin E 1 Vitamin D 1 Ultraviolet Therapy 1 Time 1 Tai Ji 1 Tablets 1 Surveys and Questionnaires 1 Sugars 1 Sodium Chloride 1 Sirolimus 1 Riluzole 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06466720 2024-12-11

CoDeB-Rad

University of Nottingham

Brain Neoplasms, Meningioma, Cognitive Dysfunction

Data powered by HemOnc (CC BY 4.0) Colophon ⚡